Fatigue in patients with cancer

European Journal of Cancer

Volumn 34, Issue 11, 1998, Pages 1670-1676

  Stone, P ^a,b   Richards, M ^c   Hardy, J ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b Trinity Hospice   (United Kingdom)

^c NONE

Author keywords

Asthenia; Fatigue; Neoplasms; Palliative care; Quality of life; Review literature

Indexed keywords

ANABOLIC AGENT; CORTICOSTEROID; PROGESTERONE; PSYCHOSTIMULANT AGENT; STEROID;

ASTHENIA; BEHAVIOR THERAPY; CACHEXIA; CANCER PALLIATIVE THERAPY; CANCER PATIENT; DEPRESSION; ENDOCRINE DISEASE; EXERCISE; FATIGUE; PATIENT INFORMATION; PERSONALITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REST; REVIEW; SCORING SYSTEM; SELF EVALUATION; STRESS; WEIGHT REDUCTION;

CACHEXIA; ENDOCRINE SYSTEM DISEASES; FATIGUE; HUMANS; NEOPLASMS; STRESS, PSYCHOLOGICAL;

EID: 0032190136     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00167-1     Document Type: Review

References (89)

1. 1. Fernsler J. A comparison of patient and nurse perceptions of patients' self-care deficits associated with cancer chemotherapy. Cancer Nurs 1986, 9(2), 50-57.
2. 2. Kubricht DW. Therapeutic self-care demands expressed by outpatients receiving external radiation therapy. Cancer Nurs 1984, 7(1), 43-52.
3. 3. Rhodes VA, Watson PM, Hanson BM. Patients' descriptions of the influence of tiredness and weakness on self-care abilities. Cancer Nurs 1988, 11(3), 186-194.
4. 4. Buccheri GF, Ferrigno D, Tamburini M, Brunelli C. The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer. Lung Cancer 1995, 12(1-2), 45-58.
5. 5. Meyerowitz BE, Sparks FC, Spears IK. Adjuvant chemotherapy for breast carcinoma: psychosocial implications. Cancer 1979, 43(5), 1613-1618.
6. 6. Frank Stromborg M, Wright P. Ambulatory cancer patients' perception of the physical and psychosocial changes in their lives since the diagnosis of cancer. Cancer Nurs 1984, 7(2), 117-130.
7. 7. Twycross R. Pain Relief in Advanced Cancer. London, Churchill Livingstone, 1994.
8. 8. Donnelly S, Walsh D, Rybicki L. The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and seventy. J Palliat Care 1995, 11(1), 27-32.
9. 9. Bruera E, MacDonald RN. Asthenia in patients with advanced cancer. Issues in symptom control. Part 1. J Pain Symptom Manage 1988, 3(1), 9-14, (erratum 3(4), 211).
10. 10. Smets EMA, Garssen B, Schuster Uitterhoeve ALJ, de Haes J. Fatigue in cancer patients. Br J Cancer 1993, 68(2), 220-224.
11. 11. Glaus A, Crow R, Hammond S. A qualitative study to explore the concept of fatigue/tiredness in cancer patients and in healthy individuals [see comments]. Support Care Cancer 1996, 4(2), 82-96.
12. 12. Ream E, Richardson A. Fatigue in patients with cancer and chronic obstructive airways disease: a phenomenological enquiry. Int J Nurs Stud 1997, 34(1), 44-53.
13. 13. Aaronson NK, Ahmedzai S, Bergmen B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85(5), 365-376.
14. 14. de Haes JC, van Kippenberg FC, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990, 62(6), 1034-1038.
15. 15. Rhoten D. Fatigue and the post surgical patient. In Norris C, ed. Concept Clarification in Nursing. Rockville, Maryland, Asped, 1982, 277-300.
16. 16. Pearson P, Byars G. The Development and Validation of a Checklist Measuring Subjective Fatigue. Randolf Airforce Base, Texas, School of Aviation, 1956.
17. 17. Krupp LB, LaRoccca NG, Muir Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46(10), 1121-1123.
18. 18. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res 1993, 37, 147-153.
19. 19. Pawlikowska T, Chalder T, Hirsch S, Wallace P, Wright D, Wessely S. A population based study of fatigue and psychological distress. Br Med J 1994, 308, 743-746.
20. 20. David A, Pelosi A, McDonald E, et al. Tired, weak, or in need of rest: fatigue among general practice attenders [see comments].. Br Med J 1990, 301(6762), 1199-1202.
21. 21. Lawrie S, Manders D, Geddes J, Pelosi A. A population-based incidence study of chronic fatigue. Psycholog Med 1997, 27, 343-353.
22. 22. Kogi K, Saito Y, Mitsuhashi T. Validity of three components of subjective fatigue feelings. J Sci Labour 1970, 46, 251-270.
23. 23. Haylock PJ, Hart LK. Fatigue in patients receiving localized radiation. Cancer Nurs 1979, 2, 461-467.
24. 24. Piper B, Lindsey A, Dodd M, Ferketich S, Paul S, Weller S. The development of an instrument to measure the subjective dimension of fatigue. In Funk S, Tornquist E, Champagne M, Copp LA, Wiese R, eds. Key Aspects of Comfort: Management of Pain, Fatigue and Nausea. New York, Springer, 1989, 199-208.
25. 25. Smets EM, Garssen B, Bonke B, de Haes JC. The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39(3), 315-325.
26. 26. Nerenz DR, Leventhal H, Love RR. Factors contributing to emotional distress during cancer chemotherapy. Cancer 1982, 50(5), 1020-1027.
27. 27. Nail LM, Jones LS, Greene D, Schipper DL, Jensen R. Use and perceived activity of self-care activities in patients receiving chemotherapy. Oncol Nurs Forum 1991, 18(5), 883-887.
28. 28. Love RR, Leventhal H, Easterling DV, Nerenz DR. Side effects and emotional distress during cancer chemotherapy. Cancer 1989, 63(3), 604-612.
29. 29. Tierney AJ, Leonard RC, Taylor J, Gloss SJ, Chetty U, Rodger A. Side effects expected and experienced by women receiving chemotherapy for breast cancer. Br Med J 1991, 302(6771), 272.
30. 30. Nail LM. Coping with intracavity radiation treatment for gynaecological cancer. Cancer Practice 1993, 1(3), 218-224.
31. 31. Hickok JT, Morrow GR, McDonald S, Bellg AJ. Frequency and correlates of fatigue in lung cancer patients receiving radiation therapy: implications for management. J Pain Symptom Manage 1996, 11(6), 370-377.
32. 32. Peck A, Boland J. Emotional reactions to radiation treatment. Cancer 1977, 40(1), 180-184.
33. 33. King KB, Nail LM, Kreamer K, Strohl RA, Johnson JE. Patients' descriptions of the experience of receiving radiation therapy. Oncol Nurs Forum 1985, 12(4), 55-61.
34. 34. Hardy JR, Turner R, Saunders M. Prediction of survival in a hospital-based continuing care unit. Eur J Cancer 1994, 30A(3), 284-288.
35. 35. Dunphy K, Amesbury B. A comparison of hospice and homecare patients: patterns of referral, patient characteristics and predictors of place of death. Palliat Med 1990, 4, 105-111.
36. 36. Walsh TD, Saunders CM. Hospice care: the treatment of pain in advanced cancer. Recent Results Cancer Res 1984, 89, 201-211.
37. 37. Vainio A, Auvinen A. Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. J Pain Symptom Manage 1996, 12(1), 3-10.
38. 38. Coyle N, Adelhardt J, Foley KM, Portenoy RK. Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life [see comments]. J Pain Symptom Manage 1990, 5(2), 83-93.
39. 39. Donnelly S, Walsh D. The symptoms of advanced cancer. Semin Oncol 1995, 22(2, Suppl. 3), 67-72.
40. 40. Dunlop G. A study of the relative frequency and importance of gastrointestinal symptoms, and weakness in patients with far advanced cancer: a student paper. Palliat Med 1989, 4, 37-43.
41. 41. McCarthy M. Hospice patients: a pilot study in 12 services. Palliat Med 1990, 4, 93-104.
42. 42. Cox B, Blaxter M, Buckle A, et al. The Health and Lifestyle Survey. London, Health Promotion Research Trust, 1987.
43. 43. Shepherd M, Cooper B, Brown A, Kalton G. Psychiatric Illness in General Practice, 2nd ed. Oxford, Oxford University Press, 1981.
44. 44. King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996, 5(6), 555-567.
45. 45. Klee M, Groenvold M, Machin D. Quality of life of Danish women: population-based norms for the EORTC-QLQ-C30. Qual Life Res 1997, 6, 27-34.
46. 46. Bruera E, Brenneis C, Michaud M, Jackson F, MacDonald R. Association between involuntary muscle function (IMF) and asthenia (AST), nutritional status (NS), lean body mass (LBM), psychometric assessment and tumour mass (TM) in patients (Pts) with advance breast cancer (Abstract 1024). Proc ASCO 1987, 6, 261.
47. 47. Bruera E, Brenneis C, Michaud M, et al. Association between asthenia and nutritional status, lean body mass, anemia, psychological status, and tumor mass in patients with advanced breast cancer. J Pain Symptom Manage 1989, 4(2), 59-63.
48. 48. Irvine D, Vincent L, Graydon JE, Bubela N, Thompson L. The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy: a comparison with the fatigue experienced by healthy individuals. Cancer Nursing 1994, 17(5), 367-378.
49. 49. McArthur M. MSc Advanced clinical practice (career nursing): a study of fatigue in cancer patients receiving chemotherapy. University of Surrey, 1992.
50. 50. Morant R. Asthenia: an important symptom in cancer patients. Cancer Treat Rev 1996, 22(Suppl. A), 117-221.
51. 51. Pickard Holley S. Fatigue in cancer patients. A descriptive study. Cancer Nurs 1991, 14(1), 13-19.
52. 52. Watanabe S, Bruera E. Anorexia and cachexia, asthenia, and lethargy. Hematol Oncol Clin North Am 1996, 10(1), 189-206.
53. 53. Morant R, Stiefel F, Berchtold W, Radziwill A, Riesen W. Preliminary results of a study assessing asthenia and related psychological and biological phenomena in patients with advanced cancer. Support Care Cancer 1993, 1(2), 101-107.
54. 54. Warmolts J, Peter K, Lewis R, et al. Type II muscle fibre atrophy (II atrophy) - an early systemic effect of cancer. Neurology 1975, 25, 374.
55. 55. Bruera E, Brenneis C, Michaud M, Jackson PI, MacDonald RN. Muscle electrophysiology in patients with advanced breast cancer. J Natl Cancer Inst 1988, 80(4), 282-285.
56. 56. Gleeson C, Spencer D. Blood transfusion and its benefits in palliative care. Palliat Med 1995, 9(4), 307-313.
57. 57. Greenway B, Iqbal MJ, Johnson PJ, Williams R. Low serum testosterone concentrations in patients with carcinoma of the pancreas. Br Med J Clin Res Ed 1983, 286(6359), 93-95.
58. 58. Todd BD. Pancreatic carcinoma and low serum testosterone; a correlation secondary to cancer cachexia? Eur J Surg Oncol 1988, 14(3), 199-202.
59. 59. Blackman MR, Weintraub BD, Rosen SW, Harman SM. Comparison of the effects of lung cancer, benign lung disease, and normal aging on pituitary-gonadal function in men. J Clin Endocrinol Metab 1988, 66(1), 88-95.
60. 60. Chlebowski RT, Heber D. Hypogonadism in male patients with metastatic cancer prior to chemotherapy. Cancer Res 1982, 42(6), 2495-2498.
61. 61. Greenberg DB, Gray JL, Mannix CM, Eisenthal S, Carey M. Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J Pain Symp Manag 1993, 8(4), 196-200.
62. 62. Derogatis LR, Morrow GR, Fetting J, et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983, 249(6), 751-757.
63. 63. Smets PM, Garssen B, Cull A, de Haes JC. Application of the multidimensional fatigue inventory (MFI-20) in cancer patients receiving radiotherapy. Br J Cancer 1996, 73(2), 241-245.
64. 64. Blakely AA, Howard RC, Sosich RM, Murdoch JC, Menkes DB, Spears GF. Psychiatric symptoms, personality and ways of coping in chronic fatigue syndrome. Psychol Med 1991, 21(2), 347-362.
65. 65. Magnusson A, Nias D, White P. Is perfectionism associated with fatigue? J Psychosom Res 1996, 41, 377-384.
66. 66. Aistars J. Fatigue in the cancer patient: a conceptual approach to a clinical problem. Oncol Nurs Forum 1987, 14(6), 25-30.
67. 67. Blesch KS, Paice JA, Wickham R, et al. Correlates of fatigue in people with breast or lung cancer. Oncol Nurs Forum 1991, 18(1), 81-87.
68. 68. Brown M, Carrieri V, Janson-Bjerklie S, Dodd M. Lung cancer and dyspnoea: the patient's perception. Oncol Nurs Forum 1986, 13, 19-24.
69. 69. Knobf MT. Physical and psychologic distress associated with adjuvant chemotherapy in women with breast cancer. J Clin Oncol 1986, 4(5), 678-684.
70. 70. Fulcher K, White P. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. Br Med J 1997, 314, 1647-1652.
71. 71. Mock V, Dow KH, Meares CJ, et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 1997, 24(6), 991-1000.
72. 72. MacVicar M, Winningham M. Promoting the functional capacity of cancer patients. Cancer Bull 1986, 38, 235-239.
73. 73. Mock V, Burke MB, Sheehan P, et al. A nursing rehabilitation program for women with breast cancer receiving adjuvant chemotherapy. Oncol Nurs Forum 1994, 21(5), 899-907.
74. 74. MacVicar MG, Winningham ML, Nickel JL. Effects of aerobic interval training on cancer patients' functional capacity. Nurs Res 1989, 38(6), 348-351.
75. 75. Young-McCaughan S, Sexton D. A retrospective investigation of the relationship between aerobic exercise and quality of life in women with breast cancer. Oncol Nurs Forum 1991, 18(4), 751-757.
76. 76. Dodd M. Patterns of self care in cancer patients receiving radiation therapy. Oncol Nurs Forum 1984, 11(3), 23-27.
77. 77. Rainey L. Effects of preparatory patient education for radiation oncology patients. Cancer 1985, 56, 1056-1061.
78. 78. Johnson J, Nail L, Lauver D, King K, Keys H. Reducing the negative impact of radiation therapy on functional status. Cancer 1988, 61, 46-51.
79. 79. Spiegel D, Bloom JR, Yalom I. Group support for patients with metastatic cancer. A randomized outcome study. Arch Gen Psychiatry 1981, 38(5), 527-533.
80. 80. Forester B, Kornfeld DS, Fleiss JL. Psychotherapy during radiotherapy: effects on emotional and physical distress. Am J Psychiatry 1985, 142(1), 22-27.
81. 81. Fawzy FI, Cousins N, Fawzy NW, Kemeny ME, Elashoff R, Morton D. A structured psychiatric intervention for cancer patients. I. Changes over time in methods of coping and affective disturbance. Arch Gen Psychiatry 1990, 47(8), 720-725.
82. 82. Cimprich B. Development of an intervention to restore attention in cancer patients. Cancer Nurs 1993, 16(2), 83-92.
83. 83. Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG. Cortico-steroid therapy of preterminal gastrointestinal cancer. Cancer 1974, 33(6), 1607-1609.
84. 84. Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 1985, 69(7-8), 751-754.
85. 85. Robustelli Delia Cuna G, Pellegrini A, Piazzi M, et al. Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. Eur J Cancer Clin Oncol 1989, 25(12), 1817-1821.
86. 86. Bruera E, Macmillan K, Kuehn N, Hanson J, MacDonald RN. A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer. Cancer 1990, 66(6), 1279-1282.
87. 87. Downer S, Joel S, Allbright A, et al. A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia. Br J Cancer 1993, 67(5), 1102-1105.
88. 88. Chlebowski RT, Herrold J, Ali I, et al. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer. Cancer 1986, 58(1), 183-186.
89. 89. Bruera E, Chadwick S, Brenneis C, Hanson J, MacDonald RN. Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Rep 1987, 71(1), 67-70.